Showing 157 to 158 of 158 results


Clearer Drug Risk Information in Ads
New FDA rules require clearer explanations of prescription drug risks and side effects in advertisements, addressing concerns about manipulative practices and the rise of online drug promotion by influencers.
Clearer Drug Risk Information in Ads
New FDA rules require clearer explanations of prescription drug risks and side effects in advertisements, addressing concerns about manipulative practices and the rise of online drug promotion by influencers.
Progress
0% Bias Score

FDA Proposes Removing Phenylephrine from Decongestants
The FDA proposes removing oral phenylephrine from over-the-counter nasal decongestants due to ineffectiveness, sparking debate among healthcare organizations.

FDA Proposes Removing Phenylephrine from Decongestants
The FDA proposes removing oral phenylephrine from over-the-counter nasal decongestants due to ineffectiveness, sparking debate among healthcare organizations.
Progress
0% Bias Score
Showing 157 to 158 of 158 results